Systematic review / meta-analysis / 2019
Viscous fiber supplements significantly improved glycemic control markers, including HbA1c and fasting blood glucose, in type 2 diabetes.
A systematic review and meta-analysis of randomized controlled trials (≥3 weeks duration) assessed the effect of viscous fiber supplementation on glycemic control in type 2 diabetes. Analyzing 28 trial comparisons (n = 1,394), viscous fiber at a median dose of ~13.1 g/day significantly reduced HbA1c (MD -0.58% [95% CI -0.88, -0.28]; P = 0.0002), fasting blood glucose (MD -0.82 mmol/L [95% CI -1.32, -0.31]; P = 0.001), and HOMA-IR (MD -1.89 [95% CI -3.45, -0.33]; P = 0.02) compared with control. The certainty of evidence was graded moderate for HbA1c, fasting glucose, fasting insulin, and HOMA-IR, and low for fructosamine.
- Study type
- Systematic review and meta-analysis of RCTs
- Who was studied
- 1,394 participants across 28 trial comparisons with type 2 diabetes
- What was measured
- HbA1c, fasting blood glucose, and HOMA-insulin resistance (HOMA-IR)
THE PAPER
Should Viscous Fiber Supplements Be Considered in Diabetes Control? Results From a Systematic Review and Meta-analysis of Randomized Controlled Trials.
Jovanovski E, Khayyat R, Zurbau A, Komishon A, Mazhar N, Sievenpiper JL, Blanco Mejia S, Ho HVT, Li D, Jenkins AL, Duvnjak L, Vuksan V. Diabetes Care, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.